Researchers crack cancer survival mechanism

A weapon cancers use to survive chemotherapy has been uncovered by UK scientists, whose findings could help make cancer treatments much more effective.

A team from the charity Cancer Research UK unravelled the structure of a protein at the heart of the tumour defence system.

Known as FANCL, it helps cancer cells to repair the DNA damage inflicted by many chemotherapy drugs.

Hide Ad
Hide Ad

Study leader Dr Helen Walden, based at Cancer Research UK's London Research Institute, said: "Our team has determined the structure of the engine in the cell's maintenance pack that if switched off would make cells much more responsive to chemotherapy.

"We have taken the first full atomic snapshot of a protein in this cell repair pathway, right at the very heart of the route by which cancer cells defend themselves against treatments which are intended to destroy them.

"By blocking this repair 'ignition switch', it may be possible to boost traditional treatments. As such, it's a drug target."

FANCL is a key component in a cell signalling system known as the "Fanconi Anaemia pathway" which was not properly understood until now.

Hide Ad
Hide Ad

Genetic faults affecting the pathway can lead to Fanconi Anaemia, an inherited disorder associated with short stature and a wide variety of cancers.

The new research, published in the journal Nature Structural and Molecular Biology, suggests that careful targeting of FANCL might help to fight cancer.

Dr Lesley Walker, director of cancer information at Cancer Research UK, said: "This is important research."

Related topics: